GMM Pfaudler FY26: Order momentum stays strong, but margins and cash efficiency remain the big watchpoints

GMM Pfaudler closed FY26 with steady topline growth and a sharp improvement in business visibility. Consolidated revenue rose to INR 3,524 crores, up 10% year-on-year, while EBITDA increased 11% to INR 403 crores, translating into an 11.4% margin. The demand backdrop was reflected even more clearly in orders: FY26 order intake climbed 20% to INR 3,714 crores and backlog expanded 34% to INR 2,194 crores.

But the year also underlined why investors continue to focus on quality of earnings. Reported consolidated PAT was INR 52 crores, a 1.5% margin, impacted by exceptional items and other below-the-line pressures. The company disclosed that PAT excluding exceptional items was INR 99 crores (2.8% margin), highlighting the gap between underlying operating performance and reported profitability.

FY26 performance: Revenue and EBITDA grew, PAT stayed compressed

The company’s five-year trend shows FY26 as a recovery from FY25 on revenue and EBITDA, but not on PAT margin. Consolidated revenue increased from INR 3,199 crores in FY25 to INR 3,524 crores in FY26. EBITDA improved from INR 361 crores to INR 403 crores. PAT, however, moved only marginally from INR 49 crores to INR 52 crores, with both years at a 1.5% net margin.

This divergence was also visible in quarterly volatility. Q4 FY26 revenue was INR 944 crores, up 17% YoY, but EBITDA declined 10% YoY to INR 75 crores, with margin falling to 8.0%. On the earnings call, management cautioned against reading too much into a single quarter, attributing the margin drop to product mix swings and temporary cost pressures like gas and metal prices. They emphasized evaluating margins on a 12-month basis given the company’s wide product range and shipment mix.

India held up well; international profitability is still being reset

The presentation highlighted stronger momentum in India. India revenue for FY26 was INR 1,034 crores, up 12%. India EBITDA was INR 135 crores, up 22%, and India PAT rose 40% to INR 59 crores. In contrast, the international segment reported FY26 revenue of INR 2,583 crores (up 9%) and EBITDA of INR 264 crores (up 3%), but PAT was negative at INR -8.6 crores.

A large part of the international PAT weakness came from exceptional items related to restructuring measures in Germany. The company reported FY26 consolidated exceptional items gross of tax at INR 65.3 crores, including INR 52.6 crores for workforce reduction measures at the Waghäusel site in Germany and INR 12.7 crores linked to the impact of the new labour code.

On the call, the Group CFO noted a minor change versus earlier expectations, with the Germany restructuring provision increasing by INR 9 crores as agreements were signed with individuals. Management said this higher cost would be accompanied by higher savings going forward.

Orders and diversification: Non-traditional sectors now a bigger driver

One of the most important structural shifts highlighted in the investor deck is the company’s diversification by sector. In the order intake mix, chemicals fell from 58% in FY23 to 35% in FY26, while non-traditional industries expanded from 23% to 42% over the same period. Pharmaceuticals were 23% in FY26.

Management reinforced this theme with examples of new types of orders that were not typical for the company a few years ago, such as an order of around INR 130 crores from nuclear and a large acid recovery order of about USD 30 million. They also acknowledged that part of the FY26 order intake acceleration came from two large systems orders, one in the US and one in Eastern Europe, and clarified that systems orders may convert to revenue over two to three years rather than immediately.

This conversion profile is also why management resisted giving near-term growth guidance. On the call, they said the strong order intake should not automatically be interpreted as next-year revenue growth of a similar magnitude, especially given macro uncertainty and the multi-year execution profile of large systems projects.

Cost actions and cash: Strong free cash flow, but structural issues persist

Cash generation remained a clear positive. The company reported consolidated free cash flow of INR 367 crores in FY26 (FY25 INR 318 crores). Working capital efficiency improved, with inventory days (net of customer advances) reducing to 22 days from 35 days. Customer advances increased to INR 427 crores from INR 236 crores, lowering net funding required for inventory.

Leverage metrics also improved. Net debt to equity was reported at 0.1x (FY25 0.2x) and net debt to adjusted EBITDA at 0.4x (FY25 0.5x).

However, investors repeatedly questioned why the EBITDA-to-PAT conversion remains weak despite low net leverage and high cash balances. Management acknowledged the concern and attributed it to inherited financing and tax structures following the Pfaudler acquisition. They discussed an intercompany loan between Germany and Luxembourg that creates FX exposure and can affect earnings and tax outcomes. The CFO also stated that tax issues are mainly linked to the Luxembourg entity and that resolving them will take time.

On capital allocation, management indicated intent to reduce debt and restructure financing. In response to investor questions, they indicated potential debt reduction of at least INR 200 crores in FY27, while also cautioning that such actions are complex due to operations across multiple jurisdictions and existing financing agreements.

What to track from here

FY26 reinforced two realities for GMM Pfaudler. First, the company has been able to sustain growth and increase business visibility even as traditional chemicals demand remains slow and macro uncertainty has risen. Second, the quality of earnings is still constrained by exceptional items and a financing and tax structure that management itself describes as inefficient.

The near-term narrative will likely be shaped by three measurable factors: conversion of the elevated backlog into revenue, delivery of the announced cost savings from the Germany restructuring, and visible progress in simplifying interest and tax leakage. Management also reiterated an aspiration to reach a 15% consolidated EBITDA margin in the medium term, but stopped short of providing a timed roadmap.

For investors, the most important takeaway is that the demand engine appears stronger than the reported earnings suggest, but the company still needs to translate that operating performance into cleaner, more predictable bottom-line results.